The Scottish Medicines Consortium (SMC) has rejected two products for use within the Scottish NHS

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1441, 2004-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Scottish Medicines Consortium (SMC) has issued guidance to the Scottish NHS regarding adefovir dipivoxil and aripiprazole.

Inpharma, Vol. 1, Iss. 1451, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Enfuvirtide, valdecoxib endorsed by Scottish Medicines Consortium

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 426, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Newly-licensed drugs recommended by Scottish Medicines Consortium

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 418, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Medicines as an investment, not a cost, for the NHS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 643, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The Chinese government has issued its first guidance covering the use of medicines

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 598, 2010-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite